Share via:
Don’t miss out on our latest stories. Add PCMag as a preferred source on Google.
Elon Musk’s brain implant start-up, Neuralink, plans to launch a US clinical trial next month of a device that it says can translate thoughts into text.
The company’s president and co-founder, Seo Dong-jin, claims that the US Food and Drug Administration has granted Neuralink an “investigational device exemption” ahead of the trial, allowing it to test unapproved products in humans, according to…
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
Don’t miss out on our latest stories. Add PCMag as a preferred source on Google.
Elon Musk’s brain implant start-up, Neuralink, plans to launch a US clinical trial next month of a device that it says can translate thoughts into text.
The company’s president and co-founder, Seo Dong-jin, claims that the US Food and Drug Administration has granted Neuralink an “investigational device exemption” ahead of the trial, allowing it to test unapproved products in humans, according to…
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi
